Simplex Trading’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-37,805
Closed -$279K 9859
2025
Q3
$279K Sell
37,805
-695
-2% -$5.91K ﹤0.01% 4558
2025
Q2
$293K Sell
38,500
-8,130
-17% -$127K ﹤0.01% 4089
2025
Q1
$889K Buy
46,630
+26,465
+131% +$832K ﹤0.01% 2810
2024
Q4
$729K Buy
20,165
+14,195
+238% +$395K ﹤0.01% 3166
2024
Q3
$171K Buy
5,970
+2,810
+89% +$62.4K ﹤0.01% 4678
2024
Q2
$80K Sell
3,160
-715
-18% -$32.5K ﹤0.01% 5606
2024
Q1
$292K Sell
3,875
-160
-4% -$12.7K ﹤0.01% 4431
2023
Q4
$415K Buy
4,035
+1,895
+89% +$170K ﹤0.01% 3896
2023
Q3
$208K Buy
2,140
+650
+44% +$60.6K ﹤0.01% 4311
2023
Q2
$174K Sell
1,490
-1,285
-46% -$163K ﹤0.01% 4456
2023
Q1
$232K Buy
2,775
+2,410
+660% +$210K ﹤0.01% 4160
2022
Q4
$31K Sell
365
-765
-68% -$58.3K ﹤0.01% 6434
2022
Q3
$35K Sell
1,130
-400
-26% -$11.1K ﹤0.01% 6897
2022
Q2
$33K Hold
1,530
﹤0.01% 7028
2022
Q1
$75K Buy
+1,530
New +$61.1K ﹤0.01% 6554

Other funds holding RVPH

Simplex Trading's RVPH Position: Q4 2025 in Review

Simplex Trading sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2025, closing a stake of 8,626 shares — an estimated $63K sold.

Simplex Trading first reported a position in RVPH in Q1 2022 and held it in 10 quarters. The position peaked at $232K in Q4 2023. 48 funds tracked by Wall St. Rank hold RVPH as of Q4 2025.

  • Simplex Trading reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 8,626 REVIVA PHARMA HLDGS INC shares in Q4 2025, an estimated $63K.
  • Simplex Trading first reported a position in REVIVA PHARMA HLDGS INC in Q1 2022 and held it in 10 quarters.
  • Simplex Trading's REVIVA PHARMA HLDGS INC position peaked at $232K in Q4 2023.
  • 48 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.